6-K 1 bbd20241101_6k.htm 6-K

 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 

 
FORM 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE
SECURITIES EXCHANGE ACT OF 1934
 
For the month of November, 2024
Commission File Number 1-15250
 

 
BANCO BRADESCO S.A. 
(Exact name of registrant as specified in its charter)
 
BANK BRADESCO
(Translation of Registrant's name into English)
 
Cidade de Deus, s/n, Vila Yara
06029-900 - Osasco - SP
Federative Republic of Brazil
(Address of principal executive office)
 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.  Form 20-F ___X___ Form 40-F _______

 Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.  

Yes _______ No ___X____

 .

 
 

 

 

Banco Bradesco S.A. (“Bradesco”) informs its shareholders and the overall market that Atlântica Hospitais e Participações, S.A. (“Atlântica”), company of investment in hospitals, indirectly controlled by Bradesco and by Bradseg Participações S.A., which is controller of Bradesco Seguros Group, signed, on this date, an Investment Agreement with Rede D’Or São Luiz S.A. Group (“Rede D’Or”) for the inclusion of Hospital São Luiz Campinas in the network of hospitals “Atlântica D’Or” (“Transaction”), expanding, thus, the partnership with Rede D’Or, disclosed to the market on May 8, 2024 (“Partnership”), maintaining the holding, in the current structure, of 50.01% for Rede D’Or and 49.99% for Atlântica. The medical management of the hospital will be under the responsibility of Rede D’Or.

 

The expansion of the Partnership is aligned with Atlântica´s strategy of investing in the healthcare value chain by means of partnerships with players stablished in hospitals operation.

 

The conclusion of the Transaction is subject to the compliance with certain suspensive conditions, usual in operations of this nature, including the due regulatory approvals.

 

Cidade de Deus, Osasco, SP, November 1st, 2024.

 

 

André Costa Carvalho

Investor Relations Officer

 

 

 
 
SIGNATURES
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Date: November 1, 2024
 
BANCO BRADESCO S.A.
By:
 
/S/André Costa Carvalho

    André Costa Carvalho
Investor Relations Officer
 
 
FORWARD-LOOKING STATEMENTS

This press release may contain forward-looking statements. These statements are statements that are not historical facts, and are based on management's current view and estimates of future economic circumstances, industry conditions, company performance and financial results. The words "anticipates", "believes", "estimates", "expects", "plans" and similar expressions, as they relate to the company, are intended to identify forward-looking statements. Statements regarding the declaration or payment of dividends, the implementation of principal operating and financing strategies and capital expenditure plans, the direction of future operations and the factors or trends affecting financial condition, liquidity or results of operations are examples of forward-looking statements. Such statements reflect the current views of management and are subject to a number of risks and uncertainties. There is no guarantee that the expected events, trends or results will actually occur. The statements are based on many assumptions and factors, including general economic and market conditions, industry conditions, and operating factors. Any changes in such assumptions or factors could cause actual results to differ materially from current expectations.